Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.āāā ā
Healthcare
Medical Instruments & Supplies
2 years
USD
Exclusive to Premium users
$4.79
Price+4.13%
$0.19
$179.358m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$4.933m
-
1y CAGR-
3y CAGR-
5y CAGR-$77.198m
-
1y CAGR-
3y CAGR-
5y CAGR-$2.11
-
1y CAGR-
3y CAGR-
5y CAGR$73.397m
$116.470m
Assets$43.073m
Liabilities$19.706m
Debt16.9%
-0.3x
Debt to EBITDA-$59.339m
-
1y CAGR-
3y CAGR-
5y CAGR